Moore Michael G, Deschler Daniel G, McKenna Michael J, Varvares Mark A, Lin Derrick T
Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114, USA.
Otolaryngol Head Neck Surg. 2007 Dec;137(6):893-8. doi: 10.1016/j.otohns.2007.09.010.
To evaluate clinical outcomes following lateral temporal bone resection (LTBR) for management of malignancies involving the ear or temporal bone.
A retrospective medical record review was performed on patients receiving LTBR for management of malignancies involving the ear or temporal bone between 1990 and 2007.
In this group of 35 patients, the mean age was 62.7 years, with tumor histopathologies including squamous cell carcinoma (SCC, 20), basal cell carcinoma (BCC, 7), adenoid cystic carcinoma (ACC, 7), and adenocarcinoma (1). The 5-year overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were 77%, 79%, and 52%, respectively. Complete resection resulted in improved OS, DSS, and DFS (P < 0.004 for each) and reduced local recurrence (P < 0.001).
In patients with carcinomas of the ear and temporal bone, upfront excision including LTBR is an effective management when combined with postoperative radiation therapy. Complete removal of all disease may improve survival and decrease recurrence.
评估外侧颞骨切除术(LTBR)治疗耳部或颞骨恶性肿瘤的临床疗效。
对1990年至2007年间接受LTBR治疗耳部或颞骨恶性肿瘤的患者进行回顾性病历审查。
在这组35例患者中,平均年龄为62.7岁,肿瘤组织病理学类型包括鳞状细胞癌(SCC,20例)、基底细胞癌(BCC,7例)、腺样囊性癌(ACC,7例)和腺癌(1例)。5年总生存率(OS)、疾病特异性生存率(DSS)和无病生存率(DFS)分别为77%、79%和52%。完整切除可提高OS、DSS和DFS(每项P<0.004)并降低局部复发率(P<0.001)。
对于耳部和颞骨癌患者,包括LTBR在内的 upfront 切除联合术后放疗是一种有效的治疗方法。完全切除所有病灶可提高生存率并降低复发率。